These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11012743

  • 1. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Leder LD, Schaefer HE.
    Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
    [Abstract] [Full Text] [Related]

  • 2. [Histologic and hematological findings in CML. A comparative immunohistochemical-morphometric and clinical study on bone marrow biopsies from 604 patients derived from two institutes of pathology (Cologne/Freiburg)].
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Schaefer HE.
    Pathologe; 2000 Jan; 21(1):39-54. PubMed ID: 10663668
    [Abstract] [Full Text] [Related]

  • 3. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl V, Zankovich R, Schaefer HE.
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [Abstract] [Full Text] [Related]

  • 4. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Spohr M, Diehl V, Zankovich R, Niederle N, Leder LD.
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients.
    Kvasnicka HM, Thiele J, Schmitt-Graeff A, Diehl V, Zankovich R, Niederle N, Leder LD, Schaefer HE.
    Br J Haematol; 2001 Mar; 112(3):727-39. PubMed ID: 11260078
    [Abstract] [Full Text] [Related]

  • 6. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Niederle N, Zirbes TK, Schmidt M, Dammasch J, Meuter BR, Leder LD, Kloke O, Diehl V.
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [Abstract] [Full Text] [Related]

  • 7. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
    Thiele J, Zirbes T, Kvasnicka HM, Niederle N, Dammasch J, Schmidt M, Windecker R, Leder LD, Diehl V, Fischer R.
    Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
    [Abstract] [Full Text] [Related]

  • 8. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Cvetanovska G, Blum N, Schaefer HE.
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [Abstract] [Full Text] [Related]

  • 9. The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia.
    Buhr T, Choritz H, Georgii A.
    Virchows Arch A Pathol Anat Histopathol; 1992 Aug; 420(6):473-8. PubMed ID: 1609507
    [Abstract] [Full Text] [Related]

  • 10. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Goekce D, Diehl V, Zankovich R, Schaefer HE.
    J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
    [Abstract] [Full Text] [Related]

  • 11. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
    Kvasnicka HM, Thiele J, Schmitt-Graeff A, Diehl V, Zankovich R, Niederle N, Leder LD, Schaefer HE.
    J Clin Oncol; 2001 Jun 15; 19(12):2994-3009. PubMed ID: 11408494
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence in-situ hybridization (FISH) reveals that in chronic myelogenous leukaemia (CML) following interferon-alpha therapy, normalization of megakaryocyte size is associated with the loss of bcr/abl translocation.
    Thiele J, Schmitz B, Gross H, Kvasnicka HM, Niederle N, Leder LD, Fischer R.
    Histopathology; 1997 Sep 15; 31(3):215-21. PubMed ID: 9354890
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Zirbes TK, Birnbaum F, Kressmann C, Melguizo-Grahmann M, Frackenpohl H, Sprungmann C, Leder LD, Diehl V, Zankovich R, Schaefer HE, Niederle N, Fischer R.
    Leuk Lymphoma; 2000 Jan 15; 36(3-4):295-308. PubMed ID: 10674901
    [Abstract] [Full Text] [Related]

  • 14. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J, Simon KG, Fischer R, Zankovich R.
    Pathol Res Pract; 1988 Aug 15; 183(4):434-45. PubMed ID: 3186544
    [Abstract] [Full Text] [Related]

  • 15. Histological and clinical evolution patterns of chronic myelocytic leukemia.
    Varma N, Varma S, Marwaha N, Garewal G.
    Indian J Cancer; 1997 Dec 15; 34(4):164-8. PubMed ID: 9715539
    [Abstract] [Full Text] [Related]

  • 16. Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan.
    Kreft A, Nolde C, Büsche G, Buhr T, Kreipe H, Georgii A.
    Eur J Haematol; 2000 Jan 15; 64(1):32-41. PubMed ID: 10680703
    [Abstract] [Full Text] [Related]

  • 17. [Successful low-dose etoposide therapy for a case of myelofibrosis with chronic myelogenous leukemia megakaryocytic predominance type].
    Katayama T, Masuoka H, Yoshida M, Watanabe R, Nishiwaki K, Shimada T, Kaito K, Ochiai S, Kobayashi M, Sakai O.
    Rinsho Ketsueki; 1992 Apr 15; 33(4):488-93. PubMed ID: 1602613
    [Abstract] [Full Text] [Related]

  • 18. [Histopathology of chronic myeloid leukemia in diagnostic biopsies of bone marrow].
    Büsche G, Buhr T, Georgii A.
    Pathologe; 1995 Jan 15; 16(1):70-4. PubMed ID: 7886017
    [Abstract] [Full Text] [Related]

  • 19. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris, Semenova EA, Turkina AG, Zakharova AV, Domracheva EV, Khoroshko ND, Frank GA.
    Arkh Patol; 2003 Jan 15; 65(4):9-12. PubMed ID: 14518186
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia.
    Thiele J, Kvasnicka HM.
    Leuk Lymphoma; 2001 Jan 15; 42(5):855-62. PubMed ID: 11697640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.